Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Pacira BioSciences
PCRX
$1.06B
| $27.7M | 0.04% |
888,391
+348,542
| +65% | +$12.4M |
|
|
TSRO
702
DELISTED
TESARO, Inc.
TSRO
| $27.7M | 0.04% |
484,245
+179,696
| +59% | +$11.6M |
|
|
STBZ
703
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $27.5M | 0.04% |
915,460
+221,694
| +32% | +$6.69M |
|
704
Crane NXT
CXT
$3.09B
| $27.5M | 0.04% |
852,653
+313,583
| +58% | +$10.2M |
|
|
ACC
705
DELISTED
American Campus Communities, Inc.
ACC
| $27.4M | 0.04% |
710,387
+662,965
| +1,398% | +$25M |
|
|
NUVA
706
DELISTED
NuVasive, Inc.
NUVA
| $27.3M | 0.04% |
523,391
-7,366
| -1% | -$374K |
|
707
Visteon
VC
$2.82B
| $27.2M | 0.04% |
247,152
+204,225
| +476% | +$25.5M |
|
708
Forum Energy Technologies
FET
$791M
| $27.2M | 0.04% |
+123,722
| New | +$34.5M |
|
709
Golar LNG
GLNG
$5B
| $27.2M | 0.04% |
993,627
+666,538
| +204% | +$18.8M |
|
710
Steven Madden
SHOO
$3.49B
| $27.2M | 0.04% |
928,188
+188,889
| +26% | +$5.71M |
|
711
Fluor
FLR
$7.01B
| $27.2M | 0.04% |
474,609
+282,699
| +147% | +$16.2M |
|
712
Emcor
EME
$36.1B
| $27.1M | 0.04% |
348,361
-48,840
| -12% | -$3.87M |
|
713
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.68B
| $27.1M | 0.04% |
192,537
+52,843
| +38% | +$7.57M |
|
714
Medifast
MED
$108M
| $27.1M | 0.04% |
289,848
+117,967
| +69% | +$8.81M |
|
|
HK
715
DELISTED
Halcon Resources Corporation
HK
| $27.1M | 0.04% |
5,561,127
+2,021,349
| +57% | +$13.7M |
|
|
MLNX
716
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $27.1M | 0.04% |
371,716
+19,019
| +5% | +$1.28M |
|
717
Teck Resources
TECK
$29.5B
| $27.1M | 0.04% |
1,051,091
-1,306,073
| -55% | -$36.8M |
|
|
GWPH
718
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $27M | 0.04% |
239,774
+41,349
| +21% | +$5.2M |
|
719
Texas Roadhouse
TXRH
$13.8B
| $27M | 0.04% |
467,283
-18,578
| -4% | -$1.07M |
|
720
WIX.com
WIX
$2.38B
| $27M | 0.04% |
339,228
+326,816
| +2,633% | +$22.9M |
|
721
Halozyme
HALO
$9.76B
| $26.9M | 0.04% |
1,373,247
-101,896
| -7% | -$1.97M |
|
722
LKQ Corp
LKQ
$5.91B
| $26.9M | 0.04% |
707,669
-573,454
| -45% | -$23.3M |
|
723
DuPont de Nemours
DD
$19.1B
| $26.8M | 0.04% |
166,312
+85,171
| +105% | +$15.4M |
|
724
Hubbell
HUBB
$25.2B
| $26.7M | 0.04% |
219,126
-165,410
| -43% | -$21.8M |
|
725
GSK
GSK
$103B
| $26.6M | 0.04% |
545,334
-915,027
| -63% | -$42.6M |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.